A bibliometric analysis of primary ovarian insufficiency from 2010 to 2020.

Bibliometric analysis CiteSpace VOSviewer premature ovarian failure primary ovarian insufficiency

Journal

Climacteric : the journal of the International Menopause Society
ISSN: 1473-0804
Titre abrégé: Climacteric
Pays: England
ID NLM: 9810959

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 5 4 2022
medline: 9 9 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

This study aimed to carry out a bibliometric analysis of primary ovarian insufficiency (POI) from 2010 to 2020 and to reveal the research status and hotspots in the future. A total of 3087 articles and reviews related to POI published from 2010 to 2020 retrieved from the Web of Science Core Collection were used for bibliometric analysis. CiteSpace and VOSviewer were adopted to analyze countries and regions, organizations, authors, journals, keywords and co-cited references. The number of publications about POI increased year by year. The USA produced the largest number of publications and the most influence in this field. The main research directions of POI can be roughly divided into four aspects according to the analysis of keywords and co-cited references: genetic research of POI; stem cell therapy for patients with POI; prediction of ovarian function; and fertility preservation of cancer patients. Genetic research and stem cell therapy may become research hotspots in the future. This study might be the first bibliometric study to analyze publications of POI from multiple indicators, in order to provide new opinions for the research trends and possible hotspots of POI.

Identifiants

pubmed: 35373679
doi: 10.1080/13697137.2022.2052841
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-503

Auteurs

Z-H Deng (ZH)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

H-J Tan (HJ)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

L Wang (L)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

P-P Long (PP)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

D Guo (D)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

R-P Quan (RP)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

M-H Zeng (MH)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

H-W Deng (HW)

Center of System Biology and Data Information, School of Basic Medical Science, Central South University, Changsha, China.
Center of Biomedical Informatics and Genomics, Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.

H-M Xiao (HM)

Institute of Reproductive & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Center of Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH